Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen

References

• Gressner OA, Weiskirchen R, Gressner AM. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007;6:7.
   PubMedGoogle Scholar
• Eyden B. The myofibroblast: Phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008;12:22–37.
   PubMed Web of Science ®Google Scholar
• Watsky MA, Weber KT, Sun Y, Postlethwaite A. New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol 2010;282:165–192.
   PubMed Web of Science ®Google Scholar
• Brenner DA, Kisseleva T, Scholten D, Paik YH, Iwaisako K, Inokuchi S, et al. Origin of myofibroblasts in liver fibrosis. Fibrogenesis tissue Repair 2012;5:S17.
   PubMedGoogle Scholar
• Avery NC, Bailey AJ. The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol biol. 2006;54: 387–395.
   PubMed Web of Science ®Google Scholar
• Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: Relevance to aging and exercise. Scand J Med Sci sports 2005;15:231–240.
   PubMed Web of Science ®Google Scholar
• Odani H, Iijima K, Nakata M, Miyata S, Kusunoki H, Yasuda Y, et al. Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: Possibility of a new marker of aging and diabetes, Biochem Biophys Res Commun 2001;285:1232–1236.
   PubMed Web of Science ®Google Scholar
• Shangari N, Bruce WR, Poon R, O’Brien PJ. Toxicity of glyoxals – role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003;31:1390–1393.
   PubMed Web of Science ®Google Scholar
• Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271:9982–9986.
   PubMed Web of Science ®Google Scholar
• James O, Day C. Non-alcoholic steatohepatitis: Another disease of affluence. Lancet 1999;353:1634–1636.
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: A tale of two “hits”? Gastroenterology 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004;99:1497–1502.
   PubMed Web of Science ®Google Scholar
• Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol 2005;100:850–855.
   PubMed Web of Science ®Google Scholar
• Narasimhan S, Gokulakrishnan K, Sampathkumar R, Farooq S, Ravikumar R, Mohan V, Balasubramanyam M. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 2010;43:815–821.
   PubMed Web of Science ®Google Scholar
• Gaens KH, Niessen PM, Rensen SS, Buurman WA, Greve JW, Driessen A, et al. Endogenous formation of Nepsilon-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. J Hepatol 2012;56:647–655.
   PubMed Web of Science ®Google Scholar
• Oliveira CP, Gayotto LC, Tatai C, Della Nina BI, Lima ES, Abdalla DS, et al. Vitamin C and vitamin E in prevention of nonalcoholic fatty liver disease (NAFLD) in choline deficient diet fed rats. Nutr J 2003;2:9.
   PubMed Web of Science ®Google Scholar
• Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, et al. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997;26:670–678.
   PubMed Web of Science ®Google Scholar
• Nakano H, Nagasaki H, Yoshida K, Kigawa G, Fujiwara Y, Kitamura N, et al. N-Acetylcysteine and anti-ICAM-1 monoclonal antibody reduce ischemia-reperfusion injury of the steatotic rat liver. Transplant Proc 1998;30:3763.
   PubMed Web of Science ®Google Scholar
• Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013;58:1497–1507.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772–1775.
   PubMed Web of Science ®Google Scholar
• Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995;92:689–693.
   PubMed Web of Science ®Google Scholar
• Iuchi Y, Okada F, Onuma K, Onoda T, Asao H, Kobayashi M, Fujii J. Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production. Biochem J 2007;402:219–227.
   PubMed Web of Science ®Google Scholar
• Yoshihara D, Fujiwara N, Ookawara T, Kato S, Sakiyama H, Yokoe S, et al. Protective role of glutathione S-transferase A4 induced in copper/zinc-superoxide dismutase knockout mice. Free Rad Biol Med 2009;47:559–567.
   PubMed Web of Science ®Google Scholar
• Ohlemiller KK, McFadden SL, Ding DL, Flood DG, Reaume AG, Hoffman EK, et al. Targeted deletion of the cytosolic Cu/Zn-superoxide dismutase gene (SOD1) increases susceptibility to noise-induced hearing loss. Audiol Neuro-Otol 1999;4:237–246.
   PubMed Web of Science ®Google Scholar
• Matzuk MM, Dionne L, Guo Q, Kumar TR, Lebovitz RM. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 1998;139:4008–4011.
   PubMed Web of Science ®Google Scholar
• Uchiyama S, Shimizu T, Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 2006;281:31713–31719.
   PubMed Web of Science ®Google Scholar
• Wang L, Jiang Z, Lei XG. Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Rad Biol Med 2012;53:1689–1696.
   PubMed Web of Science ®Google Scholar
• Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005;24:367–380.
   PubMed Web of Science ®Google Scholar
• Sentman ML, Granstrom M, Jakobson H, Reaume A, Basu S, Marklund SL. Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase. J Biol Chem 2006;281:6904–6909.
   PubMed Web of Science ®Google Scholar
• Starzynski RR, Lipinski P, Drapier JC, Diet A, Smuda E, Bartlomiejczyk T, et al. Down-regulation of iron regulatory protein 1 activities and expression in superoxide dismutase 1 knock-out mice is not associated with alterations in iron metabolism. J Biol Chem 2005;280: 4207–4212.
   PubMed Web of Science ®Google Scholar
• Starzynski RR, Canonne-Hergaux F, Willemetz A, Gralak MA, Wolinski J, Stys A, et al. Haemolytic anaemia and alterations in hepatic iron metabolism in aged mice lacking Cu,Zn-superoxide dismutase. Biochem J 2009;420:383–390.
   PubMed Web of Science ®Google Scholar
• Yoshihara D, Fujiwara N, Kato S, Sakiyama H, Eguchi H, Suzuki K. Alterations in renal iron metabolism caused by a copper/zinc-superoxide dismutase deficiency. Free Radic Res 2012;46:750–757.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr 2011;48:46–49.
   PubMed Web of Science ®Google Scholar
• Finkelstein A, Kunis G, Seksenyan A, Ronen A, Berkutzki T, Azoulay D, et al. Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One 2011;6:e22374.
   PubMed Web of Science ®Google Scholar
• Wang X, Vatamaniuk MZ, Roneker CA, Pepper MP, Hu LG, Simmons RA, Lei XG. Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid Redox Signal 2011;14:391–401.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Smith MA, Zhu X, Nunomura A, Castellani RJ, Perry G. Oxidative stress and neurodegeneration. Ann NY Acad Sci 2005;1043:545–552.
   PubMed Web of Science ®Google Scholar
• Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:E685–E694.
   Google Scholar
• Reiniger N, Lau K, McCalla D, Eby B, Cheng B, Lu Y, et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 2010;59:2043–2054.
   PubMed Web of Science ®Google Scholar
• Nagata K, Hosokawa N. Regulation and function of collagen-specific molecular chaperone, HSP47. Cell Struct Funct 1996;21:425–430.
   PubMed Web of Science ®Google Scholar
• Nagata K. Expression and function of heat shock protein 47: A collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biol 1998;16:379–386.
   PubMed Web of Science ®Google Scholar
• Koide T, Asada S, Nagata K. Substrate recognition of collagen-specific molecular chaperone HSP47. Structural requirements and binding regulation. J Biol Chem 1999;274:34523–34526.
   PubMed Web of Science ®Google Scholar
• Koide T, Aso A, Yorihuzi T, Nagata K. Conformational requirements of collagenous peptides for recognition by the chaperone protein HSP47. J Biol Chem 2000;275:27957–27963.
   PubMed Web of Science ®Google Scholar
• Koide T, Takahara Y, Asada S, Nagata K. Xaa-Arg-Gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47. J Biol Chem 2002;277:6178–6182.
   PubMed Web of Science ®Google Scholar
• Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176–184.
   PubMed Web of Science ®Google Scholar
• Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest 1992;90:282–287.
   PubMed Web of Science ®Google Scholar
• Iredale JP. Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539–548.
   PubMed Web of Science ®Google Scholar
• Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821–831.
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002;36:850–860.
   PubMed Web of Science ®Google Scholar
• Iredale J. Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair. Pharmacol Res 2008;58:129–136.
   PubMed Web of Science ®Google Scholar
• Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol 2009;8:283–291.
   PubMed Web of Science ®Google Scholar
• Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2007;22:1112–1119.
   PubMed Web of Science ®Google Scholar
• Jiang JX, Chen X, Fukada H, Serizawa N, Devaraj S, Torok NJ. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice. Hepatology 2013;58:1339–1348.
   PubMed Web of Science ®Google Scholar
• Smith PR, Thornalley PJ. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-d-fructos-1-yl)hippuryl-lysine. Eur J Biochem 1992;210:729–739.
   PubMedGoogle Scholar
• Nagai R, Ikeda K, Higashi T, Sano H, Jinnouchi Y, Araki T, Horiuchi S. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 1997;234:167–172.
   PubMed Web of Science ®Google Scholar
• Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986;261:4889–4894.
   PubMed Web of Science ®Google Scholar